EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Seroprevalence Screening of Chronic Aspergillus Infection in a Post‐Tuberculosis Cohort in Senegal: A Cross‐Sectional Study Comparing ELISA and Rapid Diagnostic Tests

Touré Mariama, Ndiaye Ibrahima Mbaye, Sow Djiby, Diallo Mamadou Alpha, Diongue Khadim, Seck Mame Cheikh, Ndiaye Mouhamadou, Ndiaye Daouda, Ndiaye Faly Diop, Fortes Louise, Denning David, Badiane Aida Sadikh

Mycoses · 2026-04 · 69 (4)

DOI: 10.1111/myc.70174 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Mycoses, online erschienen am 11.04.2026. Verfasst von Touré Mariama und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centre International de Recherche et de Formation en Génomique Appliquée et de Surveillance Sanitaire (CIGASS). Hauptthemen laut MEDLINE: Antibodies, Fungal, Pulmonary Aspergillosis, Tuberculosis, Pulmonary, Aspergillosis. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: TDR Small Grants Programme (UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic pulmonary aspergillosis (CPA) is a significant, yet often overlooked, sequela of pulmonary tuberculosis (TB), particularly in resource‐limited settings. Data on the seroprevalence of Aspergillus infection in Senegal is absent, and diagnostic capacity is limited. This study aimed to determine the seroprevalence of Aspergillus ‐specific antibodies among patients with a history of TB in Senegal and to evaluate the performance of a Rapid Diagnostic Test (RDT) against an Enzyme‐Linked Immunosorbent Assay (ELISA).

Methods

A cross‐sectional study was conducted between April 30 to August 31, 2025 at two health centers in Senegal: Wakhinane and Yeumbeul among patients presenting with chronic respiratory symptoms. After obtaining informed consent from adult participants or from parents/guardians for minors, a blood sample was collected from each participant and tested for Aspergillus antibodies using both a rapid diagnostic test (RDT) and an ELISA. Results were classified as positive, negative, invalid, or not tested. Prevalence and agreement between the two assays were calculated using valid results only. Demographic data were collected, and descriptive statistics with test performance analyses were conducted.

Results

The overall seroprevalence was significantly higher by ELISA (11.9%; 38/320) than by RDT (5.5%; 11/201). Site‐specific analysis revealed disparities: Wakhinane showed higher RDT positivity (4.5% vs. 1.0%), while Yeumbeul had higher ELISA positivity (13.5% vs. 11.2%). The cohort was predominantly male (66.0%) with a median age of 30 years. ROC analysis of the ELISA identified an optimal threshold that balanced sensitivity (78%) and specificity (89%).

Conclusion

This study provided the first serological evidence of substantial Aspergillus antibody prevalence among post‐TB patients in Senegal, suggesting a significant burden of undiagnosed CPA. The higher sensitivity of ELISA makes it essential for surveillance and confirmation, while the RDT's practicality offers a viable option for initial screening in peripheral clinics. These findings underscored the urgent need to integrate CPA diagnosis into routine post‐TB care and to strengthen fungal diagnostic capacity in West Africa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, FungalPulmonary AspergillosisTuberculosis, PulmonaryAspergillosisHumansCross-Sectional StudiesSenegalMaleFemaleRapid Diagnostic TestsEnzyme-Linked Immunosorbent AssayAdultSeroepidemiologic StudiesMiddle AgedAspergillusYoung AdultSensitivity and SpecificityAdolescentChronic DiseaseAged

Substanzen

Antibodies, Fungal

Autor:innen und Institutionen

  • Centre International de Recherche et de Formation en Génomique Appliquée et de Surveillance Sanitaire (CIGASS).
  • University Cheikh Anta Diop of Dakar.
  • Centre de Santé de Wakhinane, Dakar, Senegal.
  • Dalal Jamm Hospital, Dakar, Senegal.
  • University of Manchester, Manchester, UK.

Förderung

  • TDR Small Grants Programme (UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases)

Zitieren

APA

Mariama, T., Mbaye, N. I., Djiby, S., Alpha, D. M., Khadim, D., Cheikh, S. M., Mouhamadou, N., Daouda, N., Diop, N. F., Louise, F., David, D., & Sadikh, B. A. (2026). Seroprevalence Screening of Chronic Aspergillus Infection in a Post‐Tuberculosis Cohort in Senegal: A Cross‐Sectional Study Comparing ELISA and Rapid Diagnostic Tests. Mycoses, 69(4). https://doi.org/10.1111/myc.70174

Vancouver

Mariama T, Mbaye NI, Djiby S, Alpha DM, Khadim D, Cheikh SM, et al. Seroprevalence Screening of Chronic Aspergillus Infection in a Post‐Tuberculosis Cohort in Senegal: A Cross‐Sectional Study Comparing ELISA and Rapid Diagnostic Tests. Mycoses. 2026;69(4). doi:10.1111/myc.70174

BibTeX
@article{Mariama2026,
  author = {Mariama, Touré and Mbaye, Ndiaye Ibrahima and Djiby, Sow and Alpha, Diallo Mamadou and Khadim, Diongue and Cheikh, Seck Mame and Mouhamadou, Ndiaye and Daouda, Ndiaye and Diop, Ndiaye Faly and Louise, Fortes and David, Denning and Sadikh, Badiane Aida},
  title = {Seroprevalence Screening of Chronic Aspergillus Infection in a Post‐Tuberculosis Cohort in Senegal: A Cross‐Sectional Study Comparing ELISA and Rapid Diagnostic Tests},
  journal = {Mycoses},
  year = {2026},
  volume = {69},
  number = {4},
  doi = {10.1111/myc.70174}
}
Kostenlos starten →